Market Overview

Piper Jaffray Initiates Coverage on Orexigen Therapeutics, Inc. at Overweight, Announces $10.00 PT

Share:

Latest Ratings for OREX

DateFirmActionFromTo
Mar 2016JMP SecuritiesDowngradesMarket OutperformMarket Perform
Feb 2016JP MorganDowngradesOverweightNeutral
Feb 2016RBC CapitalDowngradesOutperformSector Perform

View More Analyst Ratings for OREX
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (OREX)